Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents

Abstract Deep eutectic solvents have been recently reported as an interesting alternative to improve the therapeutic efficacy of conventional drugs, hence called therapeutic deep eutectic solvents (THEDES). The main objective of this work was to evaluate the potential of limonene (LIM) based THEDES...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carolina V. Pereira, Joana M. Silva, Liliana Rodrigues, Rui L. Reis, Alexandre Paiva, Ana Rita C. Duarte, Ana Matias
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e1ff8dc6abe849ea80e24783adfc0a76
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e1ff8dc6abe849ea80e24783adfc0a76
record_format dspace
spelling oai:doaj.org-article:e1ff8dc6abe849ea80e24783adfc0a762021-12-02T15:09:46ZUnveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents10.1038/s41598-019-51472-72045-2322https://doaj.org/article/e1ff8dc6abe849ea80e24783adfc0a762019-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-51472-7https://doaj.org/toc/2045-2322Abstract Deep eutectic solvents have been recently reported as an interesting alternative to improve the therapeutic efficacy of conventional drugs, hence called therapeutic deep eutectic solvents (THEDES). The main objective of this work was to evaluate the potential of limonene (LIM) based THEDES as new possible systems for cancer treatment. LIM is known to have antitumor activity, however it is highly toxic and cell viability is often compromised, thus this compound is not selective towards cancer cells. Different THEDES based on LIM were developed to unravel the anticancer potential of such systems. THEDES were prepared by gently mixing saturated fatty acids menthol or ibuprofen (IBU) with LIM. Successful THEDES were obtained for Menthol:LIM (1:1), CA:LIM (1:1), IBU:LIM (1:4) and IBU:LIM(1:8). The results indicate that all the THEDES present antiproliferative properties, but IBU:LIM (1:4) was the only formulation able to inhibit HT29 proliferation without comprising cell viability. Therefore, IBU:LIM (1:4) was the formulation selected for further assessment of anticancer properties. The results suggest that the mechanism of action of LIM:IBU (1:4) is different from isolated IBU and LIM, which suggest the synergetic effect of DES. In this work, we unravel a methodology to tune the selectivity of LIM towards HT29 cell line without compromising cell viability of healthy cells. We demonstrate furthermore that coupling LIM with IBU leads also to an enhancement of the anti-inflammatory activity of IBU, which may be important in anti-cancer therapies.Carolina V. PereiraJoana M. SilvaLiliana RodriguesRui L. ReisAlexandre PaivaAna Rita C. DuarteAna MatiasNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Carolina V. Pereira
Joana M. Silva
Liliana Rodrigues
Rui L. Reis
Alexandre Paiva
Ana Rita C. Duarte
Ana Matias
Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents
description Abstract Deep eutectic solvents have been recently reported as an interesting alternative to improve the therapeutic efficacy of conventional drugs, hence called therapeutic deep eutectic solvents (THEDES). The main objective of this work was to evaluate the potential of limonene (LIM) based THEDES as new possible systems for cancer treatment. LIM is known to have antitumor activity, however it is highly toxic and cell viability is often compromised, thus this compound is not selective towards cancer cells. Different THEDES based on LIM were developed to unravel the anticancer potential of such systems. THEDES were prepared by gently mixing saturated fatty acids menthol or ibuprofen (IBU) with LIM. Successful THEDES were obtained for Menthol:LIM (1:1), CA:LIM (1:1), IBU:LIM (1:4) and IBU:LIM(1:8). The results indicate that all the THEDES present antiproliferative properties, but IBU:LIM (1:4) was the only formulation able to inhibit HT29 proliferation without comprising cell viability. Therefore, IBU:LIM (1:4) was the formulation selected for further assessment of anticancer properties. The results suggest that the mechanism of action of LIM:IBU (1:4) is different from isolated IBU and LIM, which suggest the synergetic effect of DES. In this work, we unravel a methodology to tune the selectivity of LIM towards HT29 cell line without compromising cell viability of healthy cells. We demonstrate furthermore that coupling LIM with IBU leads also to an enhancement of the anti-inflammatory activity of IBU, which may be important in anti-cancer therapies.
format article
author Carolina V. Pereira
Joana M. Silva
Liliana Rodrigues
Rui L. Reis
Alexandre Paiva
Ana Rita C. Duarte
Ana Matias
author_facet Carolina V. Pereira
Joana M. Silva
Liliana Rodrigues
Rui L. Reis
Alexandre Paiva
Ana Rita C. Duarte
Ana Matias
author_sort Carolina V. Pereira
title Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents
title_short Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents
title_full Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents
title_fullStr Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents
title_full_unstemmed Unveil the Anticancer Potential of Limomene Based Therapeutic Deep Eutectic Solvents
title_sort unveil the anticancer potential of limomene based therapeutic deep eutectic solvents
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/e1ff8dc6abe849ea80e24783adfc0a76
work_keys_str_mv AT carolinavpereira unveiltheanticancerpotentialoflimomenebasedtherapeuticdeepeutecticsolvents
AT joanamsilva unveiltheanticancerpotentialoflimomenebasedtherapeuticdeepeutecticsolvents
AT lilianarodrigues unveiltheanticancerpotentialoflimomenebasedtherapeuticdeepeutecticsolvents
AT ruilreis unveiltheanticancerpotentialoflimomenebasedtherapeuticdeepeutecticsolvents
AT alexandrepaiva unveiltheanticancerpotentialoflimomenebasedtherapeuticdeepeutecticsolvents
AT anaritacduarte unveiltheanticancerpotentialoflimomenebasedtherapeuticdeepeutecticsolvents
AT anamatias unveiltheanticancerpotentialoflimomenebasedtherapeuticdeepeutecticsolvents
_version_ 1718387785519333376